Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

2 treatments under study, led by Letrozole

Related Conditions

Often studied with 6 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 4 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

75%

3 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

3Total
Phase 3 (1)
Phase 4 (2)

Trial Status

Completed3
Unknown1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 3 completed trials

Clinical Trials (4)

Research Network

Common Treatments

  • Letrozole1
  • Routine Transdermal Oestrogen Patch1

Active Sponsors

  • Gulhane School of Medicine2
  • University College, London1
  • Rijnstate Hospital1

Top Investigators

Related Conditions

  • Primary Ovarian Insufficiency1
  • Turners Syndrome1
  • Hypothalamic Amenorrhoea1
  • Hypopituitarism1
  • Obesity1

Activity Timeline